WG
BIO icon

Winton Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Winton Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,728
Closed -$5.93M – 620
2024
Q3 		$5.93M Buy
+17,728
New +$5.63M 0.42% 56
2022
Q2 		– Sell
-410
Closed -$231K – 951
2022
Q1 		$231K Sell
410
-2,671
-87% -$1.61M 0.01% 872
2021
Q4 		$2.33M Buy
3,081
+537
+21% +$402K 0.14% 180
2021
Q3 		$1.9M Buy
2,544
+411
+19% +$308K 0.11% 205
2021
Q2 		$1.37M Buy
2,133
+252
+13% +$153K 0.07% 354
2021
Q1 		$1.07M Sell
1,881
-857
-31% -$508K 0.06% 418
2020
Q4 		$1.6M Sell
2,738
-6,664
-71% -$3.8M 0.12% 187
2020
Q3 		$4.85M Sell
9,402
-14,813
-61% -$7.5M 0.16% 129
2020
Q2 		$10.9M Buy
24,215
+2,867
+13% +$1.27M 0.28% 31
2020
Q1 		$7.48M Buy
21,348
+19,587
+1,112% +$7.2M 0.2% 127
2019
Q4 		$652K Sell
1,761
-92,286
-98% -$32.5M 0.01% 1167
2019
Q3 		$31.3M Buy
94,047
+52,194
+125% +$17M 0.37% 87
2019
Q2 		$13.1M Buy
+41,853
New +$12.5M 0.25% 146
2018
Q4 		– Sell
-1,064
Closed -$333K – 872
2018
Q3 		$333K Sell
1,064
-28,396
-96% -$8.81M 0.01% 774
2018
Q2 		$8.5M Buy
29,460
+24,502
+494% +$6.77M 0.22% 184
2018
Q1 		$1.24M Sell
4,958
-17,375
-78% -$4.42M 0.04% 437
2017
Q4 		$5.33M Buy
+22,333
New +$5.41M 0.15% 247
2014
Q4 		– Sell
-1,786
Closed -$203K – 620
2014
Q3 		$203K Sell
1,786
-1,278
-42% -$151K ﹤0.01% 654
2014
Q2 		$367K Buy
+3,064
New +$374K ﹤0.01% 615

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Winton Group's BIO Position: Q4 2024 in Review

Winton Group sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2024, closing a stake of 17,728 shares — an estimated $5.93M sold.

Winton Group first reported a position in BIO in Q2 2014 and held it in 19 quarters. The position peaked at $31.3M in Q3 2019. 457 funds tracked by Wall St. Rank hold BIO as of Q4 2024.

  • Winton Group reported no remaining Bio-Rad Laboratories Class A position as of Q4 2024 after selling out during the quarter.
  • Winton Group sold 17,728 Bio-Rad Laboratories Class A shares in Q4 2024, an estimated $5.93M.
  • Winton Group first reported a position in Bio-Rad Laboratories Class A in Q2 2014 and held it in 19 quarters.
  • Winton Group's Bio-Rad Laboratories Class A position peaked at $31.3M in Q3 2019.
  • 457 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2024.

Based on Winton Group's 13F filing for Q4 2024, filed 12 Feb 2025.